Not Even a Breakup Can Slow Down This Tiny Biotech

On Wednesday, Roche Holding Ltd. (OTC ADR: RHHBY) and Inovio Pharmaceuticals Inc. (Nasdaq: INO) announced that the biotech duo are quitting their three-year partnership.

The two biotech firms were working together on development of INO-1800 - an immunotherapy molecule targeting prostate cancer and hepatitis B.

Leave a Reply

Your email address will not be published. Required fields are marked *


Some HTML is OK